Articles

A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemia

Clinical and Experimental Onco-Haematology Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano (PN), Italy
Clinical and Experimental Onco-Haematology Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano (PN), Italy
Clinical and Experimental Onco-Haematology Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano (PN), Italy
Clinical and Experimental Onco-Haematology Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano (PN), Italy
Institute of Oncology Research, Bellinzona, Switzerland
Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA
Clinical and Experimental Onco-Haematology Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano (PN), Italy
Immunopathology and Cancer Biomarkers, Centro di RiferimentoOncologico, I.R.C.C.S., Aviano (PN), Italy
Unit of Cancer Epidemiology, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano (PN), Italy
Division of Haematology, S. Eugenio Hospital and University of Tor Vergata, Rome, Italy
Hematology Institute, Catholic University of the Sacred Heart, Fondazione Policlinico A. Gemelli, Rome, Italy
UO Molecular Pathology, Ospedale Policlinico San Martino IRCCS, Genova, Italy
Onco-Haematology Department, Centro di Riferimento Oncologico della Basilicata, I.R.C.C.S., Rionero in Vulture, Italy
Department of Internal Medicine and Haematology, Maggiore General Hospital, University of Trieste, Trieste, Italy
Department of Internal Medicine and Haematology, Maggiore General Hospital, University of Trieste, Trieste, Italy
Division of Haematology, Ferrarotto Hospital, Catania, Italy
Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland;Universita’ della Svizzera Italiana, Lugano, Switzerland
Division of Haematology, Ferrarotto Hospital, Catania, Italy
Hematology Institute, Catholic University of the Sacred Heart, Fondazione Policlinico A. Gemelli, Rome, Italy
Hematology Unit, AO, Cosenza, Italy;Biotechnology Research Unit, Aprigliano, Cosenza, Italy
Biotechnology Research Unit, Aprigliano, Cosenza, Italy;Hematogy Department and Bone Marrow Transplant Unit, Cancer Care Center, Augusta Victoria Hospital, East Jerusalem, Israel
Hematology Unit, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico and University of Milan, Milan, Italy
Department of Experimental Medicine, University of Genova, Genova, Italy
Division of Cancer and Genetics, Cardiff University, School of Medicine, Heath Park, Cardiff, UK
Division of Cancer and Genetics, Cardiff University, School of Medicine, Heath Park, Cardiff, UK;University of Sussex, Brighton and Sussex Medical School, Brighton, UK
Division of Haematology, S. Eugenio Hospital and University of Tor Vergata, Rome, Italy
Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA
Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA
Clinical and Experimental Onco-Haematology Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano (PN), Italy
Vol. 105 No. 6 (2020): June, 2020 https://doi.org/10.3324/haematol.2019.228171